Mental illness and OAT deaths

NDARC at Australia’s University of New South Wales et al evaluated a cohort study of 14,763 people with opioid use disorder on opioid agonist therapy 2006-2017.  The risk of treatment cessation was 16% higher during the 1st treatment episode for people with serious mental illness compared to those without. SMI also linked to a 35% increased all-cause mortality risk.